Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 229
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04477369 | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | ||
| NCT02415777 | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction | ||
| NCT06119958 | Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects | ||
| NCT04490434 | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs | ||
| NCT03016520 | Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers | ||
| NCT07533266 | Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT04782505 | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers | ||
| NCT01964365 | Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers | ||
| NCT01651858 | Nurigra Chewable Tablet in Healthy Adult Male Volunteers | ||
| NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
| NCT07326904 | Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease | ||
| NCT01653314 | Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers | ||
| NCT06399835 | Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis | ||
| NCT07013279 | Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines | ||
| NCT05083299 | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | ||
| NCT07539415 | A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers | ||
| NCT02947139 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers | ||
| NCT06025409 | Evaluate the Efficacy and Safety of DWJ108J | ||
| NCT02490111 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT07213310 | Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults | ||
| NCT01522586 | Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031 | ||
| NCT04784910 | Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT04819932 | Pharmacokinetics and Safety of DWJ1451 in Healthy Adults | ||
| NCT04521296 | Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo | ||
| NCT06508645 | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers | ||
| NCT05376930 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT06647888 | Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia | ||
| NCT04159961 | Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers | ||
| NCT04541485 | To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) | ||
| NCT01654640 | The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine | ||
| NCT06031987 | Long-term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes | ||
| NCT02952547 | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT03184415 | Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis | ||
| NCT05737771 | To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | ||
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | ||
| NCT01557010 | Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia | ||
| NCT06668506 | To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT07465549 | CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension | ||
| NCT06592495 | Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 | ||
| NCT01636401 | Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT01764295 | Clinical Study for Patients With Hypertension Associated With Dyslipidemia | ||
| NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus |
